NeuroTherm Acquires Smith & Nephew Interventional Spine Pain Management Assets

Purchase further expands NeuroTherm's reach into the US$5 Billion Global Interventional Pain Medicine Market

WILMINGTON, Massachusetts, April 7, 2010 - NeuroTherm announced today that they have acquired the Smith & Nephew PLC
(NYSE: SNN; LSE: SN) Interventional Spine Pain Management assets from Smith &
Nephew's subsidiaries. The acquired product line includes several innovative
interventional spine pain products including the CDS Discography System,
SPINECATH(TM) & ACUTHERM(TM) Catheters and a full radiofrequency product
line. NeuroTherm will also be a distributor of the TRUCATH(TM) Injection
System within the Interventional Spine Pain market.

To view the multimedia assets associated with this release, please click
www.prnewswire.com/news-releases/neurotherm-acquires-smith–nephew-int
erventional-spine-pain-management-assets-89991457.html

(Logo: www.newscom.com/cgi-bin/prnh/20090217/NE70925LOGO )

"This acquisition made perfect sense for us, and will go a long way
towards sustaining NeuroTherm's leading position in the interventional pain
space," says Larry Hicks, President & CEO of NeuroTherm. "The Smith & Nephew
product line is highly complementary to ours and significantly expands our
product offering. This is an exciting opportunity that will enable us to
offer a one-stop option for our customers," continues Hicks.

"We have set plans in place to combine the experience and product
knowledge of the two worldwide sales teams to allow us to provide our global
customer base with excellent products and a single point of contact," says
Jos Kerstens, VP of International Sales. NeuroTherm actively sells
interventional pain products into 58 countries around the world. "We remain
focused on helping physicians expand their practice and offer improved
patient care to patients who suffer from chronic pain," continues Kerstens.

NeuroTherm is a leading manufacturer of products used in the field of
Interventional Pain, including radio frequency generators and related
consumables used to treat chronic pain. The company was awarded a US Patent
#7,574,257 in recognition of the first multi-lesion radiofrequency generator
launch. NeuroTherm markets and sells to Interventional Pain, Interventional
Radiology, Orthopedic and Foot & Ankle Specialists. Foot & Ankle Physicians
use radiofrequency to treat pain associated with Plantar Fasciitis & Neuroma.

NeuroTherm is headquartered in Wilmington, Massachusetts with corporate
offices in London and Amsterdam. Additional information about NeuroTherm can
be found on at www.neurotherm.com

Smith & Nephew is a global medical technology business, specialising in
Orthopaedics, including Reconstruction, Trauma and Clinical Therapies;
Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in
arthroscopy and advanced wound management and is one of the leading global
orthopaedics companies. Smith & Nephew is dedicated to helping improve
people's lives. The Company prides itself on the strength of its
relationships with its surgeons and professional healthcare customers, with
whom its name is synonymous with high standards of performance, innovation
and trust. The Company operates in 32 countries around the world. Annual
sales in 2009 were US$3.8 billion.

Toni Fournier, V.P. Marketing, +1-978-436-4336, tfournier at neurotherm.com